Young Suk Park Selected Research

Young Suk Park Research Topics

Disease

124	Neoplasms (Cancer) 10/2022 - 10/2004
83	Stomach Neoplasms (Stomach Cancer) 08/2022 - 12/2005
52	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 01/2004
27	Rectal Neoplasms (Rectal Cancer) 06/2022 - 07/2010
22	Neoplasm Metastasis (Metastasis) 08/2022 - 10/2003
21	Adenocarcinoma 03/2021 - 01/2004
17	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 04/2007
17	Disease Progression 12/2021 - 01/2006
15	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2022 - 03/2006
12	Colonic Neoplasms (Colon Cancer) 11/2022 - 04/2007
8	Obesity 01/2022 - 06/2016
8	Anemia 01/2020 - 01/2006
7	Diarrhea 01/2018 - 01/2004
6	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2020
6	Nausea 05/2017 - 06/2002
5	Hemorrhage 03/2021 - 12/2009
5	Neutropenia 04/2019 - 11/2004
5	Microsatellite Instability 01/2018 - 09/2010
5	Ascites 01/2018 - 01/2011
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 06/2003
5	Hepatocellular Carcinoma (Hepatoma) 08/2012 - 11/2004
4	Morbid Obesity 12/2021 - 12/2017
4	Weight Loss (Weight Reduction) 01/2021 - 10/2017
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2019 - 12/2012
4	Fatigue 01/2018 - 03/2011
4	Carcinoma (Carcinomatosis) 09/2015 - 10/2003
4	Vomiting 06/2015 - 06/2002
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021 - 06/2015
3	Lymphatic Metastasis 12/2017 - 09/2014
3	Carcinogenesis 11/2017 - 08/2009
3	Hand-Foot Syndrome 05/2017 - 08/2007
3	Abdominal Pain (Pain, Abdominal) 10/2015 - 03/2011
3	Thrombocytopenia (Thrombopenia) 10/2014 - 11/2004
3	Anorexia 05/2012 - 08/2007
2	Aggressive Fibromatosis (Desmoid) 10/2022 - 04/2014

Drug/Important Bio-Agent (IBA)

37	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2022 - 07/2005
33	Capecitabine (Xeloda)FDA Link 06/2022 - 01/2004
23	Fluorouracil (Carac)FDA LinkGeneric 08/2022 - 04/2005
23	Irinotecan (Camptosar)FDA LinkGeneric 03/2022 - 01/2004
20	Gemcitabine FDA Link 01/2021 - 03/2006
19	Biomarkers (Surrogate Marker)IBA 09/2022 - 08/2009
18	Leucovorin (Folinic Acid)FDA Link 08/2022 - 04/2005
17	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 06/2003
14	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2003
12	Bevacizumab (Avastin)FDA Link 03/2022 - 02/2013
10	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 04/2007
9	Cetuximab (Erbitux)FDA Link 10/2019 - 04/2011
8	Simvastatin (Zocor)FDA LinkGeneric 06/2022 - 09/2009
8	Pharmaceutical PreparationsIBA 01/2021 - 01/2016
7	XELOXIBA 07/2019 - 04/2011
7	Everolimus FDA Link 01/2019 - 07/2011
6	Docetaxel (Taxotere)FDA Link 04/2019 - 01/2007
6	Monoclonal AntibodiesIBA 01/2019 - 09/2015
6	Phosphotransferases (Kinase)IBA 11/2015 - 04/2007
6	ParaffinIBA 09/2014 - 01/2004
5	Paclitaxel (Taxol)FDA LinkGeneric 08/2022 - 06/2003
5	regorafenibIBA 01/2020 - 10/2015
5	Sunitinib (Sutent)FDA Link 04/2014 - 01/2010
4	Imatinib Mesylate (Gleevec)FDA Link 10/2022 - 01/2009
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2020
4	B7-H1 AntigenIBA 01/2021 - 01/2016
4	PlatinumIBA 01/2021 - 11/2010
4	Carcinoembryonic AntigenIBA 04/2020 - 12/2017
4	DNA (Deoxyribonucleic Acid)IBA 06/2017 - 10/2002
4	Hemoglobins (Hemoglobin)IBA 06/2017 - 01/2006
4	Sorafenib (BAY 43-9006)FDA Link 01/2017 - 01/2011
4	Tyrosine Kinase InhibitorsIBA 01/2016 - 01/2011
3	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2020
3	Immune Checkpoint InhibitorsIBA 09/2022 - 01/2021
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2020 - 01/2014
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 04/2007
3	Biological ProductsIBA 01/2019 - 01/2018
3	EnzymesIBA 01/2018 - 01/2013
3	Alkaline PhosphataseIBA 01/2018 - 01/2007
3	Small Interfering RNA (siRNA)IBA 01/2018 - 12/2011
3	Messenger RNA (mRNA)IBA 01/2017 - 01/2004
3	SurvivinIBA 09/2016 - 08/2009
3	pazopanib FDA Link 06/2016 - 11/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 08/2009
3	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2009 - 11/2004
2	Calcibiotic Root Canal SealerIBA 11/2022 - 10/2015
2	Indicators and Reagents (Reagents)IBA 10/2022 - 01/2018
2	Coenzyme A (CoA)IBA 06/2022 - 11/2014

Therapy/Procedure

79	Drug Therapy (Chemotherapy) 01/2022 - 12/2002
55	Therapeutics 11/2022 - 10/2003
39	Gastrectomy 01/2022 - 01/2010
23	Chemoradiotherapy 06/2022 - 08/2004
17	Combination Drug Therapy (Combination Chemotherapy) 04/2015 - 12/2002
16	Radiotherapy 04/2022 - 09/2007
11	Bariatric Surgery 01/2022 - 10/2017
11	Neoadjuvant Therapy 08/2021 - 01/2007
11	Adjuvant Chemotherapy 11/2019 - 01/2007
5	Gastric Bypass (Roux-en-Y Gastric Bypass) 10/2021 - 10/2017
5	Salvage Therapy 01/2020 - 12/2011
5	Precision Medicine 01/2018 - 06/2011
4	Length of Stay 03/2021 - 10/2018
4	Immunotherapy 01/2021 - 09/2017
4	Adjuvant Chemoradiotherapy 12/2018 - 12/2005
4	Lymph Node Excision (Lymph Node Dissection) 06/2017 - 01/2012
3	Metastasectomy 04/2021 - 09/2010